Clinical Trial Update: Imaging Multiple Sclerosis Lesions Using Magnevist and Gadavist

View source ↗

Summary

A clinical trial investigating MRI imaging of multiple sclerosis lesions with Magnevist and Gadavist has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis

Drugs mentioned

• Gadavist (gadobutrol)
• Magnevist (gadopentetate dimeglumine)

Snippet

Sponsor: Wayne State University | Conditions: Multiple Sclerosis | Status: TERMINATED